Conserved Antibody Binding-Site Identified Across COVID-19 V

Conserved Antibody Binding-Site Identified Across COVID-19 Variants


 
A Penn State research team found that the N protein on SARS-CoV-2 is conserved across all SARS-related pandemic coronaviruses (top, from left: SARS-CoV-2, civet, SARS-CoV, MERS). The protein differs from other coronaviruses, such as those that cause the common cold (bottom, from left: OC43, HKU1, NL63 and 229E). Credit: Kelly Lab/Penn State.
Read Time:
A tiny protein of SARS-CoV-2, the coronavirus that gives rise to COVID-19, may have big implications for future treatments, according to a team of Penn State researchers.
Using a novel toolkit of approaches, the scientists uncovered the first full structure of the Nucleocapsid (N) protein and discovered how antibodies from COVID-19 patients interact with that protein. They also determined that the structure appears similar across many coronaviruses, including recent COVID-19 variants — making it an ideal target for advanced treatments and vaccines. They reported their results in Nanoscale.

Related Keywords

South Africa , United States , United Kingdom , Brazil , Deb Kelly , Michael Casasanta , Penn State Center , Protochips Inc , Penn State , Huck Chair , Molecular Biophysics , Structural Oncology , Raybiotech Life , Direct Electron , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் , பிரேசில் , டெப் கெல்லி , பென் நிலை மையம் , பென் நிலை , ஹக் நாற்காலி , மூலக்கூறு உயிர் இயற்பியல் , கட்டமைப்பு புற்றுநோயியல் , நேரடி எதிர் மின்னணு ,

© 2025 Vimarsana